Investor Relations Growth and Delivery

Consensus Estimates
Available Measures
Analyst Forecasts -
 Last Month Revisions
Fiscal Period MeanHighLowMedian# of Estimates#Up#DownMean % Change
AnnualDec 165.115.464.195.1623850.91
AnnualDec 155.125.304.715.14271341.45
AnnualDec 145.075.144.955.0627640.18
QuarterlyDec 141.301.381.221.312446-0.19
QuarterlyMar 151.261.411.151.2614234.39
QuarterlyJun 151.281.371.151.2814414.48
QuarterlySep 151.261.351.121.2813501.74
Long Term Growth 1.273.10-0.901.5064043.54
Actuals -
  Reported EPSMean EstimateSurprise % Change
AnnualDec 135.014.980.60
QuarterlyDec 131.421.401.14
QuarterlyMar 141.221.210.83
QuarterlyJun 141.231.220.75
QuarterlySep 141.321.246.49
AnnualDec 125.355.36-0.24
AnnualDec 114.974.97-0.01
P/E Ratios
PeriodP/E Ratio
FY011.58
FY111.45
FY211.34
EPS Growth Rates
Growth RatesCompanyIndustryInd. Relative
FY1/FY01.11-1.641.028
FY2/FY10.991.690.993
FY3/FY2-0.072.600.974
Data Provided by Thomson Reuters

Disclaimer: Mean Earnings Estimates are calculated by First Call based on the earnings projections made by the analysts who cover Teva. Please note that any opinions, estimates or forecasts regarding TEVA's performance made by these analysts (and therefore the Mean Estimate numbers) are theirs alone and do not represent opinions, forecasts or predictions of Teva or its management. Teva does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.